Wakeling, Alan E.
AstraZeneca,
United Kingdom
2025 Rank: 36704
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1617 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36704 | 42656 |
| Total Cites | 10076 | 10774 |
| H-index | 46 | 47 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 634 | 648 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3629 | 3701 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 4592 | 4727 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7540 | 7791 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
6.48%
|
|
Wakeling, Alan E.
AstraZeneca,
United Kingdom
2024 Rank: 33883
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1520 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33883 | 39444 |
| Total Cites | 9914 | 10618 |
| H-index | 46 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 632 | 646 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3581 | 3653 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 4540 | 4676 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7391 | 7646 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
6.63%
|
|
Wakeling, Alan E.
AstraZeneca,
United Kingdom
2023 Rank: 31013
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1422 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31013 | 36124 |
| Total Cites | 9738 | 10442 |
| H-index | 46 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 624 | 638 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3526 | 3598 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 4471 | 4607 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7244 | 7499 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
6.74%
|
|
Wakeling, Alan E.
AstraZeneca,
United Kingdom
2022 Rank: 28058
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1278 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28058 | 32387 |
| Total Cites | 9518 | 10219 |
| H-index | 45 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 616 | 630 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3454 | 3526 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 4382 | 4518 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7064 | 7317 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.40 |
| Self-Citation Percentage |
6.86%
|
|
Wakeling, Alan E.
AstraZeneca,
United Kingdom
2021 Rank: 26509
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1221 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26509 | 30661 |
| Total Cites | 9318 | 10003 |
| H-index | 45 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 604 | 618 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3383 | 3455 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 4295 | 4430 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6928 | 7177 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
6.85%
|
|
Wakeling, Alan E.
AstraZeneca,
United Kingdom
2020 Rank: 23611
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1143 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23611 | 27283 |
| Total Cites | 8999 | 9672 |
| H-index | 45 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 593 | 607 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 3277 | 3349 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 4168 | 4303 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6672 | 6913 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.40 |
| Self-Citation Percentage |
6.96%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.